Catherine Schulte
Stock Analyst at Baird
(4.34)
# 378
Out of 5,090 analysts
142
Total ratings
60.83%
Success rate
13.04%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $142 → $165 | $145.49 | +13.41% | 18 | Nov 25, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $72 → $88 | $101.06 | -12.92% | 15 | Nov 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $15 → $17 | $10.93 | +55.54% | 14 | Oct 24, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,210 → $1,230 | $1,414.86 | -13.07% | 10 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $553 → $567 | $572.77 | -1.01% | 28 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $226 → $229 | $226.25 | +1.22% | 11 | Jul 23, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $3.70 | -45.95% | 6 | May 13, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $47.01 | -8.53% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $61.68 | +10.25% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $38.65 | -1.68% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $32.30 | +2.17% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $128.96 | +117.90% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $394.81 | -45.04% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $244.55 | -91.82% | 1 | Jun 28, 2018 |
Agilent Technologies
Nov 25, 2025
Maintains: Outperform
Price Target: $142 → $165
Current: $145.49
Upside: +13.41%
Exact Sciences
Nov 4, 2025
Maintains: Outperform
Price Target: $72 → $88
Current: $101.06
Upside: -12.92%
Avantor
Oct 24, 2025
Maintains: Outperform
Price Target: $15 → $17
Current: $10.93
Upside: +55.54%
Mettler-Toledo International
Aug 4, 2025
Maintains: Neutral
Price Target: $1,210 → $1,230
Current: $1,414.86
Upside: -13.07%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $553 → $567
Current: $572.77
Upside: -1.01%
Danaher
Jul 23, 2025
Maintains: Outperform
Price Target: $226 → $229
Current: $226.25
Upside: +1.22%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $3.70
Upside: -45.95%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $47.01
Upside: -8.53%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $61.68
Upside: +10.25%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $38.65
Upside: -1.68%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $32.30
Upside: +2.17%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $128.96
Upside: +117.90%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $394.81
Upside: -45.04%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $244.55
Upside: -91.82%